Literature DB >> 15907390

[Transfusion-transmitted malaria, preventive measures].

E Candolfi1.   

Abstract

Malaria is a blood parasitic disease in the first place among the most prevalent communicable infectious diseases over the world, which leads to an increased risk of transfusion transmitted malaria. Preventive measures have been undertaken to screen blood donors such as discarding red cell donations according to the medical history, travel history and detection of malarial antibodies. However, these measures may be not sufficient and reliable to avoid the risk of transmission. Preliminary data indicates that combination of travel history, detection of malarial antibodies and antigens by commercialized kits adapted to blood transfusion centres either in endemic or non endemic areas may improve malaria transfusion risk management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907390     DOI: 10.1016/j.tracli.2005.04.014

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  7 in total

1.  The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood.

Authors:  Erhabor Osaro; Adias Teddy Charles
Journal:  J Blood Med       Date:  2011-02-06

2.  A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies.

Authors:  Cecile Doderer; Aurelie Heschung; Phillippe Guntz; Jean-Pierre Cazenave; Yves Hansmann; Alexandre Senegas; Alexander W Pfaff; Tamer Abdelrahman; Ermanno Candolfi
Journal:  Malar J       Date:  2007-02-21       Impact factor: 2.979

3.  [Prevalence of asymptomatic carriage of Plasmodium in volunteer blood donors in Kisangani, Democratic Republic of Congo].

Authors:  Jacques Ossinga Bassandja; Salomon Batina Agasa; Joris Losimba Likwela
Journal:  Pan Afr Med J       Date:  2014-04-28

4.  Post-exposure serological responses to malaria parasites in potential blood donors.

Authors:  Daniela Portugal-Calisto; Ana Raquel Ferreira; Marcelo Sousa Silva; Rosa Teodósio
Journal:  Malar J       Date:  2016-11-09       Impact factor: 2.979

5.  Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione.

Authors:  Anne K North; Nina Mufti; Theresa Sullivan; Laurence Corash
Journal:  Transfusion       Date:  2020-01-12       Impact factor: 3.157

6.  Is a Plasmodium lactate dehydrogenase (pLDH) enzyme-linked immunosorbent (ELISA)-based assay a valid tool for detecting risky malaria blood donations in Africa?

Authors:  Pascal S Atchade; Cécile Doderer-Lang; Nicodème Chabi; Sylvie Perrotey; Tamer Abdelrahman; Casimir D Akpovi; Ludovic Anani; André Bigot; Ambaliou Sanni; Ermanno Candolfi
Journal:  Malar J       Date:  2013-08-08       Impact factor: 2.979

7.  Transfusional Malaria and Associated Factors at the National Blood Transfusion Center of Niamey-Niger.

Authors:  Aminata Iro; Moustapha Mahamane Lamine; Ramatoulaye Hamidou Lazoumar; Ibrahim Alkassoum; Daou Maman; Harouna Amadou Mahaman Laouali; Mahamadou Doutchi; Seydou Maiguizo; Ibrahim Maman Laminou
Journal:  J Trop Med       Date:  2019-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.